Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-2 of 2
Keywords: Nonalcoholic fatty liver disease
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis
Available to PurchaseLaila Lavanya Gadipudi, Naresh Naik Ramavath, Alessia Provera, Chris Reutelingsperger, Emanuele Albano, Mauro Perretti, Salvatore Sutti
Journal:
Clinical Science
Clin Sci (Lond) (2022) 136 (9): 643–656.
Published: 04 May 2022
... fibrosis Macrophages Nonalcoholic fatty liver disease Osteopontin Nonalcoholic steatohepatitis (NASH) is now becoming one of the most common cause of end-stage liver disease in Western countries with a death rate ascribed to NASH-related cirrhosis accounting for 12–25% [ 1 , 2 ]. NASH is also...
Includes: Supplementary data
Articles
Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (2018) 132 (7): 791–811.
Published: 16 April 2018
...-metabolism. The metabolic conditions reviewed here include obesity, a known risk factor for all of the other metabolic conditions, as well as, cardiovascular disease, diabetes and nonalcoholic fatty liver disease. Only by further understanding the cause and result of gut dysbiosis will an adequate solution...